Long-term cost-effectiveness of tirzepatide for individuals with type 2 diabetes and comorbid obesity. Tang M, Shi L, Guan D, Winberg D, et al. Diabetes Obes Metab 2025 Jun 2. doi: 10.1111/dom.16466.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tang M, Shi L, Guan D, Winberg D, et al. Long-term cost-effectiveness of tirzepatide for individuals with type 2 diabetes and comorbid obesity. Diabetes Obes Metab 2025 Jun 2. doi: 10.1111/dom.16466.
PMID: 40452343